Resveratrol inhibits the proliferation of melanoma cells by modulating cell cycle

Int J Food Sci Nutr. 2020 Feb;71(1):84-93. doi: 10.1080/09637486.2019.1614541. Epub 2019 Jun 3.

Abstract

The aim of this study was to evaluate the inhibitory effects of resveratrol (RSV) in A375 and A431 melanoma cells, by assessing cell viability (CCK-8 assay), apoptosis through flow cytometer and cell morphology, cell cycle assay by flow cytometer and western blot (Cyclin D1, Rac1 and PCDH9). Our results demonstrated that RSV strongly inhibited A375 cells proliferation, by decreasing cell viability, promoting apoptosis and arresting cell cycle. Besides, to clarify the main factor - duration or concentration of RSV, the double variance analysis of independent factors was operated after Bartlett's test for homogeneity by R project. According to the outcomes obtained from statistical analyses, Cyclin D1 and PCDH9 were strongly affected by RSV duration while Rac1 was not influenced. In conclusion, RSV can inhibit A375 proliferation and trigger apoptosis by influencing cell cycle proteins; for these effects, treatment duration of RSV played more important role than concentration.

Keywords: Melanoma; apoptosis; cell cycle; cell morphology; resveratrol (RSV).

MeSH terms

  • Apoptosis / drug effects
  • Cell Cycle / drug effects
  • Cell Cycle Checkpoints / drug effects*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Cell Survival / drug effects
  • Cyclin D1 / metabolism
  • Humans
  • Melanoma / drug therapy*
  • Resveratrol / antagonists & inhibitors*

Substances

  • CCND1 protein, human
  • Cyclin D1
  • Resveratrol